Table I.
Variable | Percent/M (SD) |
Comparisons | |
---|---|---|---|
Cancer event | Non-cancer event | ||
(n = 100) | (n = 101) | ||
Age (years) | t(199) = −0.38, p = .70 | ||
Mean (SD) | 15.32 (3.18) | 15.14 (3.50) | |
Range | 8–21 | 8–21 | |
Gender | χ2(1) < 0.01, p = .94 | ||
Male | 50.0 | 50.5 | |
Race | χ2(1) = 0.28, p = .59a | ||
Caucasian | 74.0 | 77.2 | |
African American | 19.0 | 21.8 | |
Hispanic | 3.0 | 0 | |
Asian | 1.0 | 1.0 | |
Multiple race | 2.0 | 0 | |
SESb | χ2(4) = 8.69, p = .07 | ||
Group I | 19.0 | 6.9 | |
Group II | 17.0 | 15.8 | |
Group III | 25.0 | 36.6 | |
Group IV | 24.0 | 28.7 | |
Group V | 15.0 | 11.9 | |
Parent child reporting on | χ2(1) = 0.67, p = .41 | ||
Mother (vs. father) | 87.0 | 82.2 | |
Diagnostic category | χ2(4) = 4.88, p = .30 | ||
Acute lymphoblastic leukemia | 21.0 | 33.7 | |
Acute myeloid leukemia | 7.0 | 5.0 | |
Hodgkin’s and non-Hodgkin’s lymphoma | 13.0 | 13.9 | |
Solid tumor | 44.0 | 37.6 | |
Brain tumor | 15.0 | 9.9 | |
Years since diagnosis at Time 3 | t(199) = 4.11, p < .001 | ||
Mean (SD) | 5.91 (3.26) | 8.27 (4.72) | |
Range | 2.90–17.78 | 2.85–19.92 | |
Intensity rating of treatmentc | χ2(3) = 9.60, p = .02 | ||
Least intensive | 3.3 | 6.2 | |
Moderately intensive | 30.4 | 49.5 | |
Very intensive | 34.8 | 20.6 | |
Most intensive | 31.5 | 23.7 | |
On-treatment | 4.0 | 2.0 | – |
Relapsed | 18.0 | 13.9 | χ2(1) = 0.64, p = .42 |
Note. SES = socioeconomic status.
aRace compared as dichotomous, majority, and minority.
bSES groups are ordered highest to lowest, with Group I reflecting higher SES strata and Group V indicating lower SES strata (Barratt, 2006).
cCalculated according to Werba et al., 2007.